abstract |
The present invention relates to formula (I) which selectively modulates, modulates and / or inhibits signal transduction mediated by specific natural and / or mutant tyrosine kinases involved in various human and animal diseases such as cell proliferative, metabolic, allergic and degenerative diseases. And to novel compounds selected from 2- (3-aminoaryl) amino-4-aryl-thiazole. More specifically, these compounds are selective effective c-kit inhibitors. |